Book Value Per Share: The amount of equity available to shareholders expressed on a per common share basis. Calculated as: Total Shareholders Equity / Common Shares Outstanding
ImmunityBio, Inc. (IBRX) had Book Value Per Share of $-0.49 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$113.29M |
|
$-351.40M |
|
$0.75M |
|
$112.53M |
|
$369.31M |
|
$-256.03M |
|
$-95.58M |
|
$-351.61M |
|
$-351.61M |
|
$-351.47M |
|
$-351.47M |
|
$-351.47M |
|
$-351.47M |
|
$-256.03M |
|
$-240.50M |
|
919.86M |
|
919.86M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$314.88M |
|
$114.26M |
|
$187.02M |
|
$501.90M |
|
$61.75M |
|
$477.09M |
|
$939.72M |
|
$1.00B |
|
$-499.57M |
|
$-513.53M |
|
$-499.57M |
|
1.01B |
|
| Cash Flow Statement Financials | |
$-304.94M |
|
$-149.80M |
|
$400.24M |
|
$143.91M |
|
$89.43M |
|
$-54.48M |
|
$36.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.10 |
|
-- |
|
-- |
|
-21.22 |
|
-0.95 |
|
99.34% |
|
-226.00% |
|
-226.00% |
|
-212.29% |
|
-310.37% |
|
-310.18% |
|
$-308.78M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
0.83 |
|
2.66 |
|
137.16 |
|
70.35% |
|
68.44% |
|
-70.03% |
|
1563.42% |
|
|
Book Value Per Share |
$-0.49 |
$-0.34 |
|
$-0.33 |
|